SEATTLE, April 26, 2017 /PRNewswire/ -- CTI BioPharma
Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced that
management plans to report its first quarter 2017 financial results
on Wednesday, May 3, 2017, after the close of the U.S.
financial markets. Following the announcement, members of the
management team will host a webcast conference call to discuss the
results and provide a general corporate update at 4:30 p.m.
ET (1:30 p.m. PT). Access to the
event can be obtained as follows:
Wednesday, May 3
1:30 p.m. PT/4:30 p.m. ET/10:30 p.m.
CEST
1-888-455-2311 (domestic)
+1 719-457-2617 (international)
To access the live audio webcast or the subsequent archived
recording, visit CTI
BioPharma's website, www.ctibiopharma.com. Webcast and
telephone replays of the conference call will be available at
approximately two hours after completion of the call. Callers can
access the replay by dialing 1-888-203-1112 (domestic) or +1
719-457-0820 (international). The access code for the replay is
1369799. The telephone replay will be available
until Wednesday, May 10, 2017.
About CTI BioPharma
CTI BioPharma Corp. is a biopharmaceutical company focused on
the acquisition, development and commercialization of novel
targeted therapies covering a spectrum of blood-related cancers
that offer a unique benefit to patients and healthcare providers.
CTI BioPharma has a late-stage development pipeline, including
pacritinib for the treatment of patients with myelofibrosis. CTI
BioPharma is headquartered in Seattle,
Washington. For additional information and to sign up for
email alerts and get RSS feeds, please visit
www.ctibiopharma.com.
CTI BioPharma Contacts:
Ed Bell
+1 206-272-4345
ebell@ctibiopharma.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cti-biopharma-to-report-first-quarter-2017-financial-results-on-may-3-2017-300446540.html
SOURCE CTI BioPharma Corp.